The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Role of ceramides in nonalcoholic fatty liver disease
Open accessAbstract
Nonalcoholic fatty liver disease (NAFLD) is a chronic disease with a histological spectrum ranging from steatosis alone, to nonalcoholic steatohepatitis (NASH). The latter is associated with an increased risk for progression to cirrhosis. Ceramides are a lipid species that exert biological effects through cellular proliferation, differentiation and cell death, and interact with several pathways involved in insulin resistance, oxidative stress, inflammation, and apoptosis, all of which are linked to NAFLD. Herein, we propose a mechanism through which ceramides contribute to the development of NAFLD and progression to NASH, due in part to second messenger effects via TNF-α. A better understanding of the role of ceramides in steatohepatitis has both diagnostic and therapeutic implications for the treatment of fatty liver disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles of bioactive lipid signalling: lessons from sphingolipids
Hannun, Y. A., & Obeid, L. M. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2329 · Cited by 3,333
A lipidomic analysis of nonalcoholic fatty liver disease
Puri, P., Baillie, R. A., Wiest, M. M., Mirshahi, F., Choudhury, J., Cheung, O., Sargeant, C., Contos, M. J., & Sanyal, A. J. (2007) · Hepatology · doi:10.1002/hep.21763 · Cited by 1,338
Holland, W. L., Brozinick, J. T., Wang, L.-P., Hawkins, E. D., Sargent, K. M., Liu, Y., Narra, K., Hoehn, K. L., Knotts, T. A., Siesky, A., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.01.002 · Cited by 1,232
Insulin sensitivity: Modulation by nutrients and inflammation
Schenk, S., Saberi, M., & Olefsky, J. M. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34260 · Cited by 1,191
An Overview of Sphingolipid Metabolism: From Synthesis to Breakdown
Gault, C. R., Obeid, L. M., & Hannun, Y. A. (2010) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4419-6741-1_1 · Cited by 1,071
Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin
Holland, W. L., Miller, R. A., Wang, Z. V., Sun, K., Barth, B. M., Bui, H. H., Davis, K. E., Bikman, B. T., Halberg, N., Rutkowski, J. M., et al. (2011) · Nature Medicine · doi:10.1038/nm.2277 · Cited by 892
Ceramides in insulin resistance and lipotoxicity
SUMMERS, S. (2006) · Progress in Lipid Research · doi:10.1016/j.plipres.2005.11.002 · Cited by 848
Feldstein, A. E., Werneburg, N. W., Canbay, A., Guicciardi, M. E., Bronk, S. F., Rydzewski, R., Burgart, L. J., & Gores, G. J. (2004) · Hepatology · doi:10.1002/hep.20283 · Cited by 834
Mitochondrial dysfunction in Nash: causes, consequences and possible means to prevent it
Begriche, K., Igoudjil, A., Pessayre, D., & Fromenty, B. (2006) · Mitochondrion · doi:10.1016/j.mito.2005.10.004 · Cited by 753 · cited 2×
“Oxidative stress can lead to mitochondrial dysfunction and contribute to hepatic apoptosis, which in turn exacerbates inflammation and in many cases leads to liver fibrosis [8, 9].”
BackgroundPathogenesis of non-alcoholic fatty liver disease
Dowman, J. K., Tomlinson, J. W., & Newsome, P. N. (2010) · QJM · doi:10.1093/qjmed/hcp158 · Cited by 741
Wei, Y., Wang, D., Topczewski, F., & Pagliassotti, M. J. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00644.2005 · Cited by 735
Feldstein, A. E., Wieckowska, A., Lopez, R. A., Liu, Y.-C., Zein, N. N., & McCullough, A. J. (2009) · Hepatology · doi:10.1002/hep.23050 · Cited by 712
Self-citationHolland, W. L., Bikman, B. T., Wang, L.-P., Yuguang, G., Sargent, K. M., Bulchand, S., Knotts, T. A., Shui, G., Clegg, D. J., Wenk, M. R., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43378 · Cited by 705
Apoptosis and Necrosis in the Liver: A Tale of Two Deaths?
Malhi, H., Gores, G. J., & Lemasters, J. J. (2006) · Hepatology · doi:10.1002/hep.21062 · Cited by 691
Mechanisms of Liver Injury. I. TNF-α-induced liver injury: role of IKK, JNK, and ROS pathways
Schwabe, R. F., & Brenner, D. A. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00422.2005 · Cited by 685
Bioactive sphingolipids: metabolism and function
Bartke, N., & Hannun, Y. A. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800080-jlr200 · Cited by 683
Haus, J. M., Kashyap, S. R., Kasumov, T., Zhang, R., Kelly, K. R., DeFronzo, R. A., & Kirwan, J. P. (2009) · Diabetes · doi:10.2337/db08-1228 · Cited by 663
Self-citationMitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis
Marí, M., Caballero, F., Colell, A., Morales, A., Caballeria, J., Fernandez, A., Enrich, C., Fernandez-Checa, J. C., & García-Ruiz, C. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.07.006 · Cited by 608
Increased Hepatic and Circulating Interleukin-6 Levels in Human Nonalcoholic Steatohepatitis
Wieckowska, A., Papouchado, B. G., Li, Z., Lopez, R., Zein, N. N., & Feldstein, A. E. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01774.x · Cited by 597
Self-citationHolland, W. L., & Summers, S. A. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0025 · Cited by 595
Molecular Mechanisms of Lipotoxicity in Nonalcoholic Fatty Liver Disease
Malhi, H., & Gores, G. (2008) · Seminars in Liver Disease · doi:10.1055/s-0028-1091980 · Cited by 538
Hepatocyte Death: A Clear and Present Danger
Malhi, H., Guicciardi, M. E., & Gores, G. J. (2010) · Physiological Reviews · doi:10.1152/physrev.00061.2009 · Cited by 477
Mantena, S. K., King, A. L., Andringa, K. K., Eccleston, H. B., & Bailey, S. M. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.12.029 · Cited by 429
Ceramides as modulators of cellular and whole-body metabolism
Bikman, B. T., & Summers, S. A. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57144 · Cited by 419
Epidemiology and Natural History of Non-Alcoholic Steatohepatitis
Argo, C. K., & Caldwell, S. H. (2009) · Clinics in Liver Disease · doi:10.1016/j.cld.2009.07.005 · Cited by 389
Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis
Semple, R. K., Sleigh, A., Murgatroyd, P. R., Adams, C. A., Bluck, L., Jackson, S., Vottero, A., Kanabar, D., Charlton-Menys, V., Durrington, P., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37432 · Cited by 344
Kolak, M., Westerbacka, J., Velagapudi, V. R., Wågsäter, D., Yetukuri, L., Makkonen, J., Rissanen, A., Häkkinen, A.-M., Lindell, M., Bergholm, R., et al. (2007) · Diabetes · doi:10.2337/db07-0111 · Cited by 317
Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis
Polyzos, S. A., Toulis, K. A., Goulis, D. G., Zavos, C., & Kountouras, J. (2011) · Metabolism · doi:10.1016/j.metabol.2010.09.003 · Cited by 311
Yang, G., Badeanlou, L., Bielawski, J., Roberts, A. J., Hannun, Y. A., & Samad, F. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.91014.2008 · Cited by 295
Pathophysiology of Nonalcoholic Steatohepatitis
Başaranoğlu, M. (2009) · Cited by 293
Trauner, M., Arrese, M., & Wagner, M. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.10.007 · Cited by 291
Molecular mechanisms involved in NAFLD progression
Malaguarnera, M., Di Rosa, M., Nicoletti, F., & Malaguarnera, L. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0464-1 · Cited by 282
Yetukuri, L., Katajamaa, M., Medina-Gomez, G., Seppänen-Laakso, T., Vidal-Puig, A., & Orešič, M. (2007) · BMC Systems Biology · doi:10.1186/1752-0509-1-12 · Cited by 263
Li, D.-D., Wang, L.-L., Deng, R., Tang, J., Shen, Y., Guo, J.-F., Wang, Y., Xia, L.-P., Feng, G.-K., Liu, Q. Q., et al. (2009) · Oncogene · doi:10.1038/onc.2008.441 · Cited by 259
Pathophysiology of Nonalcoholic Steatohepatitis
WATANABE, S. (2017) · Juntendo Medical Journal · doi:10.14789/jmj.63.230 · Cited by 257
Hepatic triglyceride synthesis and nonalcoholic fatty liver disease
Choi, S. S., & Diehl, A. M. (2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3282ff5e55 · Cited by 255
The role of fatty acids in the development and progression of nonalcoholic fatty liver disease
Gentile, C. L., & Pagliassotti, M. J. (2008) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2007.10.001 · Cited by 252
Kotronen, A., Seppänen-Laakso, T., Westerbacka, J., Kiviluoto, T., Arola, J., Ruskeepää, A.-L., Orešič, M., & Yki-Järvinen, H. (2009) · Diabetes · doi:10.2337/db08-1074 · Cited by 245
Adiponectin, a key adipokine in obesity related liver diseases.
Buechler, C., Wanninger, J., & Neumeier, M. (2011) · PubMed · doi:10.3748/wjg.v17.i23.2801 · Cited by 242
Pathophysiology of nonalcoholic steatohepatitis.
McCullough, A. J. (2006) · PubMed · doi:10.1097/01.mcg.0000168645.86658.22 · Cited by 215
Self-citationJeBailey, L., Wanono, O., Niu, W., Roessler, J., Rudich, A., & Klip, A. (2007) · Diabetes · doi:10.2337/db06-0823 · Cited by 209
An apoptosis panel for nonalcoholic steatohepatitis diagnosis
Tamimi, T. I. A.-R., Elgouhari, H. M., Alkhouri, N., Yerian, L. M., Berk, M. P., Lopez, R., Schauer, P. R., Zein, N. N., & Feldstein, A. E. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.08.023 · Cited by 184
Self-citationApoptosis as a Mechanism for Liver Disease Progression
Guicciardi, M. E., & Gores, G. (2010) · Seminars in Liver Disease · doi:10.1055/s-0030-1267540 · Cited by 184
de Mello, V. D. F., Lankinen, M., Schwab, U., Kolehmainen, M., Lehto, S., Seppänen-Laakso, T., Orešič, M., Pulkkinen, L., Uusitupa, M., & Erkkilä, A. T. (2009) · Diabetologia · doi:10.1007/s00125-009-1482-9 · Cited by 181
Miller, R. A., Chu, Q., Le Lay, J., Scherer, P. E., Ahima, R. S., Kaestner, K. H., Foretz, M., Viollet, B., & Birnbaum, M. J. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45942 · Cited by 179
Kotronen, A., Seppänen‐Laakso, T., Westerbacka, J., Kiviluoto, T., Arola, J., Ruskeepää, A., Yki‐Järvinen, H., & Orešič, M. (2010) · Obesity · doi:10.1038/oby.2009.326 · Cited by 179
Ceramide Synthases: Roles in Cell Physiology and Signaling
Stiban, J., Tidhar, R., & Futerman, A. H. (2010) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4419-6741-1_4 · Cited by 171
Adiponectin, a key adipokine in obesity related liver diseases
Christa, Buechler, Josef, Wanninger, Markus, M. L., & Neumeier (2011) · Acta Scientiarum Naturalium Universitatis Sunyatseni · Cited by 167
Liu, C., Tao, Q., Sun, M., Wu, J. Z., Yang, W., Jian, P., Peng, J., Hu, Y., Liu, C., & Liu, P. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2010.123 · Cited by 166
Wueest, S., Rapold, R. A., Schumann, D. M., Rytka, J. M., Schildknecht, A., Nov, O., Chervonsky, A. V., Rudich, A., Schoenle, E. J., Donath, M. Y., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci38388 · Cited by 162
The Extended Family of Neutral Sphingomyelinases
Clarke, C. J., Snook, C. F., Tani, M., Matmati, N., Marchesini, N., & Hannun, Y. A. (2006) · Biochemistry · doi:10.1021/bi061307z · Cited by 160
Stiban, J., Caputo, L., & Colombini, M. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700480-jlr200 · Cited by 158
Ceramide channels and their role in mitochondria-mediated apoptosis
Colombini, M. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.01.021 · Cited by 143
Nikolova‐Karakashian, M., & Rozenova, K. A. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6741-1_6 · Cited by 141
nSMase2 activation and trafficking are modulated by oxidative stress to induce apoptosis
Levy, M., Castillo, S. S., & Goldkorn, T. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.04.013 · Cited by 124
Critical role of acidic sphingomyelinase in murine hepatic ischemia-reperfusion injury
Llacuna, L., Marí, M., García‐Ruiz, C., Fernández-Checa, J. C., & Morales, A. (2006) · Hepatology · doi:10.1002/hep.21285 · Cited by 115
Huang, H., Kasumov, T., Gatmaitan, P., Heneghan, H., Kashyap, S. R., Schauer, P. R., Brethauer, S. A., & Kirwan, J. P. (2011) · Obesity · doi:10.1038/oby.2011.107 · Cited by 114
Self-citationApoptotic Sphingolipid Ceramide in Cancer Therapy
Huang, W., Chen, C., Lin, Y.-S., & Lin, C. (2011) · Journal of Lipids · doi:10.1155/2011/565316 · Cited by 113
Kasumov, T., Huang, H., Chung, Y., Zhang, R., McCullough, A. J., & Kirwan, J. P. (2010) · Analytical Biochemistry · doi:10.1016/j.ab.2010.02.023 · Cited by 102
Self-citationNovel Pathway of Ceramide Production in Mitochondria
Novgorodov, S. A., Wu, B. X., Gudz, T. I., Bielawski, J., Ovchinnikova, T. V., Hannun, Y. A., & Obeid, L. M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.214866 · Cited by 101
Edelmann, B., Bertsch, U., Tchikov, V., Winoto‐Morbach, S., Perrotta, C., Jakob, M., Adam‐Klages, S., Kabelitz, D., & Schütze, S. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.326 · Cited by 99
Marí, M., Colell, A., Morales, A., Caballero, F., Moles, A., Fernández, A., Terrones, O., Basáñez, G., Antonsson, B. E., García‐Ruiz, C., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.01.073 · Cited by 98
Ceramide in Redox Signaling and Cardiovascular Diseases
Li, X., Becker, K. A., & Zhang, Y. (2010) · Cellular Physiology and Biochemistry · doi:10.1159/000315104 · Cited by 95
Frangioudakis, G., Garrard, J. M., Raddatz, K., Nadler, J. L., Mitchell, T. W., & Schmitz‐Peiffer, C. (2010) · Endocrinology · doi:10.1210/en.2010-0250 · Cited by 90
Lightle, S. A., Tosheva, R., Lee, A. S., Queen-Baker, J., Boyanovsky, B. B., Shedlofsky, S., & Nikolova‐Karakashian, M. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.08.031 · Cited by 87
Mitochondrial Abnormality and Oxidative Stress in Nonalcoholic Steatohepatitis
Kojima, H., Sakurai, S., Uemura, M., Fukui, H., Morimoto, H., & 玉川泰浩 (2007) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2006.00288.x · Cited by 86
High fat diet induces ceramide and sphingomyelin formation in rat’s liver nuclei
Chocian, G., Chabowski, A., Żendzian‐Piotrowska, M., Harasim‐Symbor, E., Łukaszuk, B., & Górski, J. (2010) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-010-0409-6 · Cited by 83
Role of Neutral Sphingomyelinases in Aging and Inflammation
Nikolova‐Karakashian, M., Karakashian, A., & Rutkute, K. (2008) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-1-4020-8831-5_18 · Cited by 82
Kuo, T., Tatsukawa, H., Matsuura, T., Nagatsuma, K., Hirose, S., & Kojima, S. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22833 · Cited by 81
Promrat, K., Longato, L., Wands, J. R., & de la Monte, S. M. (2011) · Hepatology Research · doi:10.1111/j.1872-034x.2011.00815.x · Cited by 66
Ribaux, P., & Iynedjian, P. B. (2003) · Biochemical Journal · doi:10.1042/bj20031287 · Cited by 60
Clarke, C. J., Cloessner, E., Roddy, P. L., & Hannun, Y. A. (2011) · Biochemical Journal · doi:10.1042/bj20101752 · Cited by 55
Phosphatidylcholine/sphingomyelin metabolism crosstalk inside the nucleus
Albi, E., Lazzarini, R., & Magni, M. V. (2008) · Biochemical Journal · doi:10.1042/bj20070758 · Cited by 43
Heneghan, H., Huang, H., Kashyap, S. R., Gornik, H. L., McCullough, A. J., Schauer, P. R., Brethauer, S. A., Kirwan, J. P., & Kasumov, T. (2011) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2011.11.018 · Cited by 39
Self-citationChang, Z.-Q., Lee, S., Kim, H., Kim, J. R., Kim, S. J., Hong, I., Oh, B., Choi, C., Goldberg, I. J., & Park, T. (2010) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2010.12.003 · Cited by 38
Ceramides: A new player in the inflammation–insulin resistance paradigm?
Gill, J. M. R., & Sattar, N. A. (2009) · Diabetologia · doi:10.1007/s00125-009-1546-x · Cited by 36
Increase of Ceramide in the Liver and Plasma after Carbon Tetrachloride Intoxication in the Rat
Ichi, I., Nakahara, K., Fujii, K., Iida, C., Miyashita, Y., & Kojo, S. (2007) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.53.53 · Cited by 32
Predictors of Steatohepatitis and Advanced Fibrosis in Non-Alcoholic Fatty Liver Disease
Pagadala, M. R., Zein, C. O., & McCullough, A. J. (2009) · Clinics in Liver Disease · doi:10.1016/j.cld.2009.07.011 · Cited by 32
Self-citationGD3–7-aldehyde is an apoptosis inducer and interacts with adenine nucleotide translocase
Brenner, C., Kniep, B., Maillier, E., Martel, C., Franke, C., Röber, N., Bachmann, M. P., Rieber, E. P., & Sandhoff, R. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.11.044 · Cited by 13
Cited by
Lipotoxicity and the gut-liver axis in NASH pathogenesis
Marra, F., & Svegliati-Baroni, G. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.11.014 · Cited by 847
Krishnan, S., Ding, Y., Saedi, N., Choi, M., Sridharan, G. V., Sherr, D. H., Yarmush, M. L., Alaniz, R. C., Jayaraman, A., & Lee, K. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.109 · Cited by 679
Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease
Jiang, C., Xie, C., Li, F., Zhang, L., Nichols, R. G., Krausz, K. W., Cai, J., Qi, Y., Fang, Z.-Z., Takahashi, S., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76738 · Cited by 693
The Liver as an Endocrine Organ—Linking NAFLD and Insulin Resistance
Watt, M. J., Miotto, P. M., De Nardo, W., & Montgomery, M. K. (2019) · Endocrine Reviews · doi:10.1210/er.2019-00034 · Cited by 615
Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease
Mota, M., Banini, B. A., Cazanave, S. C., & Sanyal, A. J. (2016) · Metabolism · doi:10.1016/j.metabol.2016.02.014 · Cited by 570
Metadata
- Authors
- Pagadala, M., Kasumov, T., McCullough, A. J., Zein, N. N., & Kirwan, J. P.
- Venue
- Trends in Endocrinology & Metabolism
- Publisher
- Elsevier BV
- Published
- 2012-08
- Volume
- 23
- Issue
- 8
- Pages
- 365-371
- ISSN
- 1043-2760 (ISSN-L)
- OpenAlex
- W2026244691
- Cited by
- 303
- References
- 79
- FWCI
- 1.91
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.